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Abstract
Background: The aim of this study was to investigate ventricular functions and left atrial
(LA) mechanical functions, atrial electromechanical coupling, and P wave dispersion in scle-
roderma patients.
Methods: Twenty-six patients with scleroderma and twenty-four controls were included. Left
and right ventricular (LV and RV) functions were evaluated using conventional echocardio-
graphy and tissue Doppler imaging (TDI). LA volumes were measured using the biplane area-
-length method and LA mechanical function parameters were calculated. Inter-intraatrial
electromechanical delays were measured by TDI. P wave dispersion was calculated by 12-lead
electrocardiograms.
Results: LV myocardial performance indices (MPI) and RV MPI were higher in patients
with scleroderma (p = 0.000, p = 0.000, respectively) while LA passive emptying fraction was
decreased and LA active emptying fraction was increased (p = 0.051, p = 0.000, respectively).
P wave dispersion and inter-intraatrial electromechanical delay were significantly higher in
patients with scleroderma (25 [10–60] vs 20 [0–30], p = 0.000, 16.50 [7.28–26.38] vs 9.44
[3.79–15.78] and 11.33 [4.88–16.06] vs 4.00 [0–12.90], p < 0.05, respectively). Interatrial
electromechanical delay was negatively correlated with LV E wave, (p = 0.018). LV E wave
was demonstrated to be a factor independent of the interatrial electromechanical delay (R2 =
= 0.270, b = –0.52, p = 0.013).
Conclusions: This study showed that in scleroderma patients, global functions of LV, RV and
mechanical functions of LA were impaired, intra-interatrial electromechanical delays were
prolonged and P wave dispersion was higher. LV E wave was demonstrated to be a factor that
is independent of the interatrial electromechanical delay. Reduced LV E wave may also give
additional information on the process of risk stratification of atrial fibrillation. (Cardiol J
2011; 18, 3: 261–269)
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Introduction
Scleroderma is a systemic disease characteri-
zed by the involvement of the skin and visceral
organs [1]. Cardiac involvement may be present
asymptomatically and is observed in 30% of auto-
psies [1, 2]. It may be a result of the sclerosing in-
flammatory process. Previous studies have demon-
strated diffuse myocardial fibrosis and conduction
disturbances [2, 3]. Fibrosis due to collagen depo-
sition leads to both right ventricular (RV) and left
ventricular (LV) systolic and diastolic dysfunction,
conduction disturbances, and atrial and ventricular
arrhythmias [4]. Atrial arrhythmias have been re-
ported in 10–20% of patients with scleroderma [5,
6]. The mechanisms that cause atrial fibrillation
(AF) are not completely understood. Atrial inflam-
mation might promote AF [7]. This inflammatory
process may play a role that results in AF in scle-
roderma also.
Left atrial (LA) volume as a LA functional in-
dex has recently been identified as a potential indi-
cator of cardiac disease and atrial arrhythmia. LA
functions are important determinants of ventricu-
lar filling. Parameters of LA function may provide
additional information about resistance before the
filling of the ventricle. Additionally, the atrial emp-
tying pattern is strongly affected by LV diastolic
properties.
The prolongation of intraatrial and interatrial
conduction time and P wave dispersion (Pd) are well
known electrophysiological charecteristics of the
AF prone atrium [8, 9]. Intraatrial and interatrial
conduction time has been evaluated by Pd and tis-
sue Doppler imaging (TDI) [10, 11].
Our aim was to investigate the functions of LV,
RV and LA, atrial electromechanical coupling with
TDI, and also to demonstrate Pd in patients with
scleroderma.
Methods
Twenty-six patients with scleroderma (medi-
an age 48.5 [range 21–71] years; 24 female, two
male) and twenty-four age-matched and gender-
matched control subjects (median age 46.0 [22–56]
years; 22 female, two male) were included. Patients
with right bundle or left bundle branch block, pace-
maker implantation, valvular heart disease, heart
failure and taking beta-blockers, digitalis or antiar-
rhythmic drugs were excluded. All patients were
observed to be in sinus rhythm and were asymp-
tomatic in terms of heart failure and pulmonary
hypertension.
The study protocol was approved by the Local
Ethics Committee and written informed consent
was obtained from each patient.
Echocardiography
In all patients, two-dimensional, M-mode,
pulsed and color flow Doppler echocardiographic
examinations (Vivid 7 Pro, GE, Horten, Norway,
2–4 Mhz phased-array transducer) were performed
by one cardiologist. During echocardiography, a sin-
gle lead electrocardiogram was recorded simulta-
neously. Data was recorded from the average of
three cardiac cycles. M-mode and Doppler measure-
ments were performed adhering to American Socie-
ty of Echocardiography guidelines [12]. Peak sys-
tolic (Sm) and early (Em) and late (Am) diastolic
velocities were obtained from the mitral lateral, sep-
tal and tricuspid lateral annuluses. The myocardial
performance index (MPI) was calculated using TDI
methods for right and left ventricles [13].
Left atrial mechanical function
Left atrial volumes were measured echocardio-
graphically by the biplane area length method from
the apical four-chamber views. LA maximal volume
(Vmax) was recorded at the onset of the mitral
opening, LA minimal volume (Vmin) at the onset
of mitral closure, and LA presystolic volume (Vp)
at the beginning of the atrial systole (P wave on
ECG). LA emptying function parameters were cal-
culated according to the LA maximal, minimal and
presystolic volumes (LA passive emptying volume
= Vmax–Vp, LA passive emptying fraction =
[Vmax–Vp]/Vmax, LA active emptying volume =
Vp–Vmin, LA active emptying fraction = [Vp–Vmin]/Vp
and total emptying volume = Vmax–Vmin) [14, 15].
All volume measurements were corrected with re-
spect to the body surface area (BSA).
Atrial electromechanical coupling
Tissue Doppler echocardiography was per-
formed with transducer frequencies of 3.5–4.0 MHz
by adjusting the spectral pulsed Doppler signal fil-
ters until a Nyquist limit of 15 to 20 cm/s was
reached, and by using the minimal optimal gain. The
monitor sweep speed was set at 100 mm/s. In the
apical four-chamber view, the pulsed Doppler sam-
ple volume was placed at the level of LV lateral
mitral annulus, septal mitral annulus, and RV tri-
cuspid annulus. Atrial electromechanical coupling
(PA), the time interval from the onset of the P wave
on the surface electrocardiogram to the beginning
of the late diastolic wave (Am); was obtained from
the lateral mitral annulus (PAlat), septal mitral
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annulus (PAsep), and tricuspid annulus (PAtricus)
(Fig. 1). The difference between PAlat and PAtri-
cus was defined as the interatrial electromechani-
cal delay, while the difference between PAsep and
PAtricus was defined as the intraatrial electrome-
chanical delay [16]. These PA measures were cor-
rected with respect to the heart rate.
Electrocardiography
A 12-lead electrocardiogram was used to mea-
sure the maximum (Pmax) and minimum (Pmin)
P wave durations. The difference between the Pmax
and the Pmin was defined as Pd (Pd = Pmax –
– Pmin). The paper speed was 50 mm/s. The Pd
were measured manually. Mean values for three
complexes were calculated in each lead.
Statistical analysis
All continuous variables were expressed as
mean ± standard deviation and median (min–max).
Categorical data is given as counts (percentages)
and analyzed with the c2 test. Mean values of con-
tinuous variables were compared within groups
using the Student t test or Mann-Whitney U test,
and their distributions were evaluated by the Kol-
mogorov-Smirnov and Shapiro-Wilk test. Pearson’s
correlation and Spearman rho were used to assess
the relationship between continuous variables.
Stepwise, multiple regression analysis was used to
identify the significant determinants of interatrial
electromechanical delay. All predeterminant inde-
pendent variables which correlated with a p value
of less than 0.1 in Pearson’s correlation were in-
serted into a stepwise, multiple regression analy-
sis. P values < 0.05 were accepted as statistically
significant.
Results
Baseline demographic and
clinical characteristics
Clinical and laboratory findings of the subjects
are shown in Table 1. The median disease duration
was 60 (range 12–276) months. Age, sex, body mass
index (BMI), heart rate, systolic and diastolic blood
pressures and exercise capacity were similar in both
groups (p > 0.05). Pmax and Pd were significantly
higher in patients with scleroderma (106.82 ± 11.29
vs 100.00 ± 8.85, p = 0.004 and 25 [10–60] vs 20
[0–30], p = 0.000, respectively) whereas Pmin was
significantly lower in the scleroderma group (75.45 ±
± 11.84 vs 83.33 ± 9.17, p = 0.004).
Figure 1. Measurement of time interval from the onset
of P wave on surface electrocardiogram to the beginning
of Am wave (PA) interval with tissue Doppler imaging.
Table 1. Clinical and laboratory characteristics of the study population.
Scleroderma (n = 26) Controls (n = 24) P
Age (years) 48.50 (21–71) 46.00 (22–56) 0.122**
Female/male (%) 24/2 (92.3/7.7) 22/2 (91.7/8.3) 1.000***
BMI [kg/m2] 25.96 ± 4.65 27.00 ± 4.88 0.985*
Heart rate [bpm] 79.27 ± 8.99 80.16 ± 11.05 0.886*
SBP [mm Hg] 125.41 ± 7.96 123.08 ± 9.39 0.250*
DBP [mm Hg] 71.13 ± 6.62 68.20 ± 6.43 0.198*
Six-minute walking test [m] 531.82 ± 57.94 515.42 ± 37.66 0.844*
Pmax [ms] 106.82 ± 11.29 100.00 ± 8.85 0.024
Pmin [ms] 75.45 ± 11.84 83.33 ± 9.17 0.004
Pd [ms] 25 (10–60) 20 (0–30) 0.000**
Disease duration (months) 60.00 (12.00–276.00) – –
BMI — body mass index; SBP — systolic blood pressure; DBP — diastolic blood pressure; Pmax — maximum P wave duration; Pmin — minimum
P wave duration; Pd — P wave dispersion; *independent t test; **Mann-Whitney U test; ***Fisher’s Exact c2
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Echocardiographic characteristics
Echocardiographic characteristics of the study
groups are shown in Table 2. LV end-diastolic di-
mension, LVEF, LV mass, LA and RA dimensions
and LV Sm were similar in both groups. Right ven-
tricle fractional area change (RVFAC) and tricus-
pid annular plane systolic excursion (TAPSE) were
significantly lower in patients with scleroderma
(46.95 ± 5.41 vs 49.63 ± 4.81 and 23.32 ± 1.62 vs
25.75 ± 2.77, p < 0.05, respectively). In Doppler
and tissue Doppler echocardiographic examination,
LV E/A ratio was significantly lower (0.94 ± 0.37
vs 1.18 ± 0.34, p = 0.016) while LV deceleration time
was higher in patients with scleroderma (215.41 ±
± 37.31 vs 191.25 ± 27.74, p = 0.023). RV corrected
isovolumetric relaxation time and PAcct were also
lower in the scleroderma group (65.68 ± 7.02 vs
47.42 ± 3.68 and 119.82 ± 11.11 vs 142.04 ± 13.51,
p < 0.05, respectively). LV and RV MPI values were
significantly higher in scleroderma patients (0.41 ±
± 0.03 vs 0.34 ± 0.04, p = 0.000 and 0.41 ± 0.03 vs
0.31 ± 0.04, p = 0.000, respectively).
Left atrial mechanical function
LA volume indices are shown in Table 3. Vmax,
Vp, Vmin and LA passive emptying volumes were
similar in both groups (p > 0.05). LA active empty-
ing volumes and LA total emptying volumes were
significantly increased in the scleroderma group
compared to healthy controls (9.16 [5.88–19.65]
vs 5.83 [2.38–12.50], p = 0.000 and 16.39 [9.04–
–28.25] vs 14.96 [5.35–20.19], p = 0.037). LA pas-
sive emptying fraction was decreased in patients
with scleroderma (29.63 [12.10–48.95] vs 35.05
[16.30–65.20], p = 0.051). In addition, LA active
emptying fraction was significantly increased in
scleroderma patients (56.97 ± 8.95 vs 42.35 ± 7.80,
p = 0.000).
Table 2. Echocardiographic characteristics of the study population.
Scleroderma (n = 26) Controls (n = 24) P
LV end-diastolic dimension [mm] 44.91 ± 3.80 46.58 ± 3.02 0.149*
Septum thickness [mm] 9.45 ± 0.74 9.08 ± 0.88 0.038*
LVEF (%) 65.22 ± 3.91 66.33 ± 4.87 0.197*
LV mass index (g/m2] 78.60 ± 15.43 76.08 ± 14.20 0.217*
LA diameter [mm] 36.23 ± 4.14 35.79 ± 3.68 0.318*
Mitral E wave [m/s] 0.67 ± 0.14 0.73 ± 0.15 0.162**
Mitral A wave [m/s] 0.76 ± 0.15 0.65 ± 0.16 0.088*
Deceleration time [ms] 215.41 ± 37.31 191.25 ± 27.74 0.023*
LV E/A 0.94 ± 0.37 1.18 ± 0.34 0.016**
LV E/Em 5.8 (3.98–11) 5.4 (3.40–9.20) 0.037**
LV Sm [cm/s] 8.45 ± 1.36 8.13 ± 1.35 0.507*
LV Em [cm/s] 11.05 ± 3.05 11.19 ± 3.71 0.833*
LV Am [cm/s] 11.61 ± 2.60 10.79 ± 2.68 0.380*
LV MPI 0.41 ± 0.03 0.34 ± 0.04 0.000*
RVFAC (%) 46.95 ± 5.41 49.63 ± 4.81 0.045*
TAPSE [mm] 23.32 ± 1.62 25.75 ± 2.77 0.000*
RV Sm [cm/s] 13.77 ± 1.72 15.04 ± 1.76 0.001**
RV Em [cm/s] 15.22 ± 2.79 14.58 ±  2.86 0.734*
RV Am [cm/s] 16.82 ± 4.18 17.54 ± 5.20 0.715*
RV IVCTc [ms] 67.36 ± 10.23 54.33 ± 7.03 0.000*
RV IVRTc [ms] 65.68 ± 7.02 47.42 ± 3.68 0.000*
RV MPI 0.41 ± 0.03 0.31 ± 0.04 0.000*
PAcct [ms] 119.82 ± 11.11 142.04 ± 13.51 0.000*
RA diameter [mm] 29.18 ± 2.44 29.91 ± 2.60 0.254*
LV — left ventricle; EF — ejection fraction; LA — left atrium; Sm — systolic myocardial velocity; Em — early myocardial diastolic velocity; Am — late
myocardial diastolic velocity; MPI — myocardial performance index; RVFAC — right ventricle fractional area change; TAPSE — tricuspid annular pla-
ne systolic excursion; RV — right ventricle; IVCTc — corrected isovolumetric contraction time; IVRTc — corrected isovolumetric relaxation time;
PAcct — pulmonary artery acceleration time; RA — right atrium; *independent t test; **Mann-Whitney U test
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Atrial electromechanical coupling
Table 4 shows atrial electromechanical cou-
pling findings measured by TDI. PAlat and PAsep
were significantly higher in patients with scleroder-
ma compared to controls (63.15 [52.40–79.48] vs
58.50 [5.52–71.06], 57.25 [50.62–72.00] vs 51.81
[42.58–70.87], p £ 0.05). However, PA tricuspid
was similar in both groups (45.83 [34.56–58.89] vs
48.16 [39.95–61.15], p = 0.290). Increased intera-
trial (PAlat–PAtricus) and intraatrial (PAsep–
–PAtricus) electromechanical delays were observed
in patients with scleroderma (16.50 [7.28–26.38] vs
9.44 [3.79–15.78] and 11.33 [4.88–16.06] vs 4.00 [0–
–12.90], p < 0.05, respectively).
Relationship between interatrial
electromechanical delay and other
clinical and laboratory characteristics
Interatrial electromechanical delay was positive-
ly correlated with disease duration and LA diameter
(r = 0.524, p = 0.006 and r = 0.419, p = 0.033,
respectively) and negatively correlated with LV
E wave, TAPSE, RV E wave and exercise capacity
(r = –0.461, p = 0.018, r = –0.513, p = 0.007,
Table 3. Left atrial volume measurements of the study population.
Scleroderma (n = 26) Controls (n = 24) P
Vmax [mL/m2] 25.65 ± 7.72 22.45 ± 6.48 0.236**
23.13 (11.81–38.98) 23.17 (10.16–34.52)
Vp [mL/m2] 18.37 ± 6.31 14.32 ± 5.30 0.060**
17.41 (9.03–30.73) 14.35 (4.91–23.08)
Vmin [mL/m2] 7.91 ± 2.90 8.24 ± 3.25 0.568*
7.76 (2.77–13.96) 8.43 (2.48–14.33)
LA PEV [mL/m2] 7.28 ± 3.52 8.12 ± 3.37 0.534**
6.85 (2.35–15.23) 7.85 (2.67–14.55)
LA PEF (%) 28.28 ± 10.76 36.80 ± 12.82 0.051**
29.63 (12.10–48.95) 35.05 (16.30–65.20)
LA AEV [mL/m2] 10.49 ± 4.25 6.08 ± 2.64 0.000**
9.16 (5.88–19.65) 5.83 (2.38–12.50)
LA AEF (%) 56.97 ± 8.95 42.35 ± 7.80 0.000*
57.35 (39.50–69.79) 42.36 (29.92–55.30)
LA TEV [mL/m2] 17.76 ± 5.84 14.18 ± 3.93 0.037**
16.39 (9.04–28.25) 14.96 (5.35–20.19)
Vmax — left atrial maximum volume; Vp — left atrial volume at the beginning of atrial systole; Vmin — left atrial minimal volume; LA — left atrium;
PEV — passive emptying volume; PEF — passive emptying fraction; AEV — active emptying volume; AEF — active emptying fraction; TEV — total
emptying volume; *independent t test; **Mann-Whitney U test
Table 4. Atrial electromechanical coupling findings measured by tissue Doppler imaging.
Scleroderma (n = 26) Controls (n = 24) P
PA lateralc [ms] 63.78 ± 7.91 58.31 ± 5.52 0.003*
63.15 (52.40–79.48) 58.50 (5.52–71.06)
PA septumc [ms] 58.22 ± 5.95 53.00 ± 6.08 0.001**
57.25 (50.62–72.00) 51.81 (42.58–70.87)
PA tricuspidc [ms] 47.34 ± 6.00 48.92 ± 5.52 0.290*
45.83 (34.56–58.89) 48.16 (39.95–61.15)
PA lateral–PA tricuspid [ms] 16.44 ± 5.30 9.39 ± 2.84 0.000**
16.50 (7.28–26.38) 9.44 (3.79–15.78)
PA septum–PA tricuspid [ms] 10.89 ± 3.25 4.08 ± 3.57 0.000**
11.33 (4.88–16.06) 4.00 (0–12.90)
PA — time interval from the onset of P wave on surface electrocardiogram to the beginning of Am wave interval with tissue Doppler imaging;
PA lateral–PA tricuspid — interatrial electromechanical delay; PA septum–PA tricuspid — intraatrial electromechanical delay; *independent t test;
**Mann-Whitney U test
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r = –0.563, p = 0.003 and r = 0.436, p = 0.043,
respectively). No significant correlation was found
between interatrial electromechanical delay and
age, BMI, LV MPI, LV E/A, LV E/E’ or RV MPI
(Table 5). In stepwise linear regression analysis, LV
E wave was demonstrated to be an independent
factor of interatrial electromechanical delay (R2 =
= 0.270, b = –0.52, p = 0.013; Table 6).
Discussion
This study showed that in patients with scle-
roderma, firstly, diastolic and systolic functions of
left and right ventricles and LA mechanical func-
tions were impaired; secondly, intra-interatrial elec-
tromechanical delay was increased and Pd was high-
er; and lastly, LV E wave was demonstrated to be
an independent factor of interatrial electromechani-
cal delay.
Ithas already been demonstrated that fibrosis
due to collagen deposition leads to RV and LV sys-
tolic and diastolic dysfunction [4]. Poanta et al. [17]
also showed that diastolic function parameters were
impaired in asymptomatic scleroderma patients
compared to controls. D’Andrea et al. [18] reported
LV myocardial involvement in asymptomatic pa-
tients with scleroderma. Recently, subclinical
biventricular impairment was demonstrated in scle-
roderma patients by the use of pulsed-wave TDI
[19]. Likewise, our study found that both ventricle
diastolic and systolic functions were impaired be-
fore any clinical sign or symptom in patients with
scleroderma. Otherwise, in our study, isolated sys-
tolic dysfunction was not shown to be present. The
finding of LV global dysfunction was demonstrated
by the abnormal MPI. So, we deduced that addition
of MPI to standard measurements may provide ear-
ly detection of heart involvement.
RV dysfunction in scleroderma patients is re-
lated to the specific collagen deposition. It is also
known that due to the specific changes in sclero-
derma, pulmonary hypertension may develop. The
presence of pulmonary hypertension will also lead
to the development of RV dysfunction. It has been
shown that structural abnormalities of small coro-
nary arteries and arterioles are present in sclero-
derma-related pulmonary hypertension and cause
impaired RV function due to ischemia of the RV
[20]. Given late presentation of the signs of pulmo-
nary hypertension, physicians cannot be expected
to make a diagnosis of pulmonary hypertension
based on clinical features alone. Earlier detection
of pulmonary hypertension in scleroderma is cru-
cial so as to allow earlier treatment and prevent
disease progression. The estimation of systolic
pulmonary artery pressure by Doppler echocardio-
graphy depends on an adequate Doppler signal from
Table 5. Correlation between interatrial
electromechanical delay and clinical
echocardiographic characteristics.
r p
Age (years) 0.250 0.218
Body mass index [kg/m2] 0.237 0.244
Disease duration (months) 0.524 0.006
Exercise capacity (%) –0.436 0.043
Six-minute walking distance [m] –0.645 0.001
New York Heart Association 0.335 0.038
LV MPI 0.316 0.116
LV E wave [m/s] –0.461 0.018
LV E/A 0.020 0.923
LV E/Em 0.049 0.813
LA [mm] 0.419 0.033
RV MPI 0.197 0.335
TAPSE [mm] –0.513 0.007
RV Em [cm/s] –0.563 0.003
LA passive emptying fraction 0.068 0.740
LA active emptying fraction –0.086 0.677
LV — left ventricle; LA — left atrium; RV — right ventricle; MPI —
myocardial performance index; TAPSE — tricuspid annular plane
systolic excursion
Table 6. Relation between interatrial
electromechanical delay and clinical and
echocardiographic characteristics.
b t p
Disease duration 0.29 1.54 0.141
(months)
Sex 0.13 0.58 0.569
LVEF (%) 0.02 0.11 0.910
LV MPI 0.12 0.61 0.547
LV E/E’ 0.18 0.90 0.382
LV E/A 0.03 0.17 0.866
LV E wave [m/s] –0.52 –2.72 0.013*
LV A wave [m/s] –0.07 –0.33 0.742
LV S wave [m/s] 0.31 1.55 0.138
RV MPI 0.06 0.31 0.757
TAPSE [mm] –0.27 –1.37 0.186
LA passive emptying 0.10 0.44 0.665
fraction
LA active emptying –0.08 –0.39 0.702
fraction
LVEF — left ventricular ejection fraction; rest abbreviations as in
Table 5; *p < 0.05 is significant
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tricuspid regurgitation. It may be absent in 26% of
patients [21]. Thus, latent pulmonary hypertension
may not be determined in asymptomatic scleroder-
ma patients. Huez et al. [22] suggested that RV
dysfunction is related to latent pulmonary hyperten-
sion. Patients in our study also showed no clinical
evidence of pulmonary hypertension, and systolic
pulmonary artery pressure estimated by Doppler
echocardiography was < 35 mm Hg. Nevertheless,
PAcct as an indicator of pulmonary hypertension and
RV diastolic dysfunction is shorter in scleroderma
patients than in the control group. So, in our study,
RV dysfunction may be a  preclinical warning of
asymptomatic pulmonary hypertension.
Atrial enlargement is known to be associated
with increased mortality in the general population
[23]. LA diameter is correlated with cardiovascular
disease and is accepted as a risk factor of AF [23,
24]. A recently published study showed that cardi-
ac arrhythmias, especially those of supraventricu-
lar origin, are most frequent in sclerodema patients
[25]. Assessment of atrial functions may be based
on the atrial volumes. Direct damage to the atrial
tissue, and indirect damage arising from atrial over-
load, may influence the mechanical functions of the
atrium. LA function is an important determinant of
ventricular filling [26]. It has been demonstated that
in diabetic patients, decreased LA passive empty-
ing volume is related to increased end-diastolic LV
pressure, whereas, increased LA active emptying
volume is associated with compensatory mecha-
nisms in LA contraction [14]. We also showed that
LA mechanical functions and diastolic function pa-
rameters were impaired in patients with sclero-
derma. So, we speculate that atrial arrhythmias may
develop in these patients due to impaired LA func-
tions.
Interatrial electromechanical coupling times
may be prolonged due to atrial tissue damage in
scleroderma patients [27]. Deniz et al. [28] found
an increase in intraatrial mechanical delay in pa-
roxysmal AF patients. Earlier invasive studies have
stated the normal values for electrical conduction
as 77 ± 8 ms [29]. In previous studies, electrome-
chanical coupling intervals were also used in differ-
ent clinical manifestations [30]. This method can be
used as an early marker to detect paroxysmal AF.
The geometrical distance between two atria is an
important determining factor for atrial conduction,
and inter-nodal pathways may play an important role
in interatrial electromechanical delay [31]. Conven-
tionally, atrial electrical function has been evaluat-
ed from electrocardiography (ECG) and invasive
electrophysiological techniques [32]. Mostly be-
cause of the high cost and because they are inva-
sive, the current use of electrophysiological tech-
niques is limited. Fujimoto et al. [33] demonstrat-
ed the presence of abnormal atrial contractions in
scleroderma. Abnormal atrial contractions may be
supposed to affect atrial electrical conduction. Con-
sistent with the earlier studies, we demonstrated
the delayed interatrial electromechanical coupling
intervals in scleroderma patients [31, 34].
Atrial arrhythmias have been evaluated by both
short period ECG and ambulatory ECG [5, 6]. Pd is
a simple electrocardiographic predictor of paroxys-
mal lone AF [8]. In addition, changes in LA microar-
chitecture may predispose to paroxysmal AF by de-
creasing atrial myocardial contraction and increas-
ing Pd [35]. Can et al. [34] reported that patients
with scleroderma showed increased Pd and Pmax
values. In another study, longer signal averaged
P wave durations were demonstrated in patients with
scleroderma [31]. In this study, we also demonstrat-
ed an increased Pd in scleroderma patients. It may
be concluded that these patients had an increased
risk of AF. Due to the limitations of Pd evaluation
methods, Dilaveris et al. [36] demonstrated differ-
ent methods of P wave analysis using a 12-lead
ECG. Nevertheless, P wave measurements from
the standard surface ECG were readily available,
simple to operate and cheaper than other methods.
In addition, other methods are not widely commer-
cially available. In our study, we used surface ECG
to evaluate Pd.
Studies have investigated whether the echo-
cardiographic parameters of the LA predicts the
development of AF [37]. Choi et al. [38] demonstrat-
ed that reduced A’, which is a parameter of LA con-
tractile function, might be an important predictor
for the development of nonvalvular AF. LA dilata-
tion is frequently observed in LV diastolic dysfunc-
tion. Impaired ventricular relaxation is related to
a lower atrio-ventricular gradient. So, this may
cause a reduction of early transmitral flow (low E
wave velocity) in the relaxation type of diastolic dys-
function [39]. A relation between LA dilatation and
interatrial electromechanical delay has been de-
monstrated in previous studies [16, 40]. In the
present study, LV E wave was negatively correlat-
ed with interatrial electromechanical delay and may
be accepted as an independent factor of the inter-
atrial electromechanical delay.
Clinical implications
There are three main implications of our study.
The identification of a risk of AF process could be
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of interest in asymptomatic scleroderma patients.
The assessment of LA mechanical and electrome-
chanical functions is accepted as a risk factor of AF.
We showed that LA mechanical functions were
impaired and interatrial electromechanical delays
were prolonged in asymptomatic scleroderma pa-
tients. However, current use of these echocardio-
graphic methods is limited. We also showed that LV
E wave derived by pulse wave Doppler was de-
monstrated to be an independent factor of the in-
teratrial electromechanical delay. So, we conclud-
ed that addition of reduced LV E wave to these
methods may give additional information on the
process of risk stratification of AF. Moreover, LV
E wave can be readily measured and is simpler to
operate than other echocardiographic methods at
the bedside during routine echocardiographic exa-
mination.
Pulmonary hypertension may lead to signifi-
cant RV dysfunction. Earlier detection of pulmonary
hypertension in scleroderma is crucial to initiating
earlier treatment and preventing disease progres-
sion. We found that PAcct as an indicator of pulmo-
nary hypertension and RV diastolic dysfunction is
shorter in scleroderma patients. So, we deduced
that RV dysfunction may be a preclinical warning
of asymptomatic pulmonary hypertension.
Our study did not find isolated systolic dysfunc-
tion. LV global dysfunction was demonstrated by
the abnormal MPI. Addition of MPI to standard
measurements may provide early detection of heart
involvement. It is possible that it may be used to
determine LV global function instead of isolated
systolic dysfunction. But further studies are need-
ed before this can be used in clinical practice. Thus,
ventricular function, especially MPI, is important
in evaluating these patients before the onset of
symptoms.
Limitations of the study
We did not follow up in terms of the develop-
ment of AF. This may be the most important limi-
tation of our study. Such patients must be followed-
up for a longer period to determine atrial arrhyth-
mia. Further studies with follow-up are necessary
to investigate whether AF occurs in scleroderma
patients. In addition, our study is limited by the lack
of other investigations of cardiac involvement, such
as invasive correlation for diastolic dysfunction and
myocardial scintigraphy or magnetic resonance.
A final limitation of our study is the relatively small
group of patients.
Conclusions
This study showed that in patients with asymp-
tomatic scleroderma: firstly, diastolic and systolic
functions of left and right ventricles and LA mechani-
cal functions were impaired; secondly, that intra-
interatrial electromechanical delays were prolonged
and Pd was higher; and thirdly, that LV E wave was
demonstrated to be an independent factor of the
interatrial electromechanical delay. Reduced LV
E wave may also give additional information on the
process of risk stratification of AF.
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